Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling

NARecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2030

Conditions
Heart FailureLeft Ventricular DysfunctionIdiopathic Dilated Cardiomyopathy
Interventions
DIAGNOSTIC_TEST

Thermodilution based assessment of coronary microcirculation

Coronary microvascular assessment with the derivation of CFR, IMR and MRR will be performed using a standard pressure/thermodilution guidewire.

Trial Locations (9)

37126

RECRUITING

Azienda Ospedaliera Universitaria di Verona, Verona

Unknown

NOT_YET_RECRUITING

Azienda Ospedaliera Universitaria di Ferrara, Ferrara

NOT_YET_RECRUITING

Cardiothoracic and Vascular Department (DICATOV) IRCCS, Ospedale Policlinico San Martino, Genova

NOT_YET_RECRUITING

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) dell'Ospedale San Raffaele, Milan

NOT_YET_RECRUITING

Ospedale Galeazzi di Sant'Ambrogio IRCCS, Milan

NOT_YET_RECRUITING

University of Naples Federico II, Naples

NOT_YET_RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

NOT_YET_RECRUITING

Azienda Ospedaliero-Universitaria Sant'Andrea, Rome

NOT_YET_RECRUITING

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Azienda Ospedaliera Universitaria Integrata Verona

OTHER

NCT06356727 - Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling | Biotech Hunter | Biotech Hunter